Metropolitan Life Insurance CO Oric Pharmaceuticals, Inc. Transaction History

Metropolitan Life Insurance CO

$253 Million
Q2 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 10, 2023	BUY	$4.95 - $8.4 $10,637 - $18,051	2,149 New	2,149 $16,000
Q1 2022 May 12, 2022	SELL	$4.54 - $16.1 $39,529 - $140,182	-8,707 Closed	0 $0
Q4 2021 Jun 21, 2023	BUY	$12.01 - $20.3 $104,571 - $176,752	8,707 New	8,707 $127,000
Q4 2021 Mar 30, 2023	BUY	$12.01 - $20.3 $1,933 - $3,268	161 Added 1.88%	8,707 $127,000
Q4 2021 Feb 15, 2022	BUY	$12.01 - $20.3 $1,933 - $3,268	161 Added 1.88%	8,707 $128,000
Q3 2021 Jun 21, 2023	BUY	$15.9 - $25.22 $135,881 - $215,530	8,546 New	8,546 $178,000
Q3 2021 Mar 30, 2023	BUY	$15.9 - $25.22 $19,938 - $31,625	1,254 Added 17.2%	8,546 $178,000
Q3 2021 Nov 15, 2021	BUY	$15.9 - $25.22 $19,938 - $31,625	1,254 Added 17.2%	8,546 $179,000
Q2 2021 Jun 21, 2023	BUY	$17.37 - $25.34 $126,662 - $184,779	7,292 New	7,292 $128,000
Q2 2021 Mar 30, 2023	BUY	$17.37 - $25.34 $11,950 - $17,433	688 Added 10.42%	7,292 $128,000
Q2 2021 Aug 16, 2021	BUY	$17.37 - $25.34 $126,540 - $184,601	7,285 Added 104071.43%	7,292 $129,000
Q1 2021 Jun 26, 2023	BUY	$23.67 - $36.85 $156,316 - $243,357	6,604 New	6,604 $162 Million
Q1 2021 May 14, 2021	SELL	$23.67 - $36.85 $156,150 - $243,099	-6,597 Reduced 99.89%	7 $162,000
Q4 2020 Jun 22, 2023	BUY	$20.32 - $39.8 $134,193 - $262,839	6,604 New	6,604 $223,000
Q4 2020 Mar 30, 2023	BUY	$20.32 - $39.8 $69,433 - $135,996	3,417 Added 107.22%	6,604 $223,000
Q4 2020 Feb 16, 2021	BUY	$20.32 - $39.8 $134,193 - $262,839	6,604 New	6,604 $224,000
Q3 2020 Nov 13, 2020	SELL	$19.5 - $31.26 $62,146 - $99,625	-3,187 Closed	0 $0
Q2 2020 Jun 26, 2023	BUY	$25.68 - $38.12 $81,842 - $121,488	3,187 New	3,187 $107,000
Q2 2020 Mar 30, 2023	BUY	$25.68 - $38.12 $81,842 - $121,488	3,187 New	3,187 $107,000
Q2 2020 Aug 14, 2020	BUY	$25.68 - $38.12 $81,842 - $121,488	3,187 New	3,187 $107,000

Others Institutions Holding ORIC

# of Institutions

112

Shares Held

63.1M

Call Options Held

Put Options Held

View Full List

About Oric Pharmaceuticals, Inc.

Ticker ORIC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,576,700
Market Cap $406M
Description
ORIC Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for treatment of cancers in the United States. Its clinical stage product candidates include ORIC-533, an orally bioavailable small molecule inhibitor of CD73 being developed for resistance to chemotherapy- and immunotherapy-based treatment r...

More about ORIC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Metropolitan Life Insurance CO, based on Form 13F filings with the SEC.

News

Stay updated on Metropolitan Life Insurance CO with notifications on news.

Account